文献速递血液净化与透析

延长家庭血液透析与中心常规血液透析的患者生存比较

Patient Survival With Extended Home Hemodialysis Compared to In-Center Conventional Hemodialysis.
PubMed 文献 · Kidney Int Rep · 2023-09-15

本多中心倾向评分匹配研究比较了349例延长家庭血液透析(HHD)患者与1047例中心常规血液透析(ICHD)患者的长期结局。HHD平均透析时长418±54分钟,ICHD为242±10分钟。意向性分析显示HHD全因死亡风险较ICHD低40%(HR=0.60;95%CI 0.45-0.80;P<0.001),且HHD在磷酸盐、血压控制、营养炎症指标及住院天数方面更优。

要点

  • 延长HHD与ICHD相比,全因死亡风险降低40%(HR=0.60)。
  • HHD组5年技术生存率为86.5%。
  • HHD可改善磷酸盐和血压控制,减少住院天数及用药需求。

核心结论

  • 延长家庭血液透析与中心常规血液透析相比,与更高的生存率和更好的临床结局相关。

研究设计与样本

  • 多中心研究,采用倾向评分匹配349例2010-2014年开始HHD的患者与1047例同期ICHD患者。
  • 随访至2018年9月30日,主要结局为总生存率。

主要发现

  • HHD平均透析时长418±54分钟,ICHD为242±10分钟。
  • HHD和ICHD全因死亡率分别为3.76和6.27每100患者年。
  • 意向性分析中HHD全因死亡风险较ICHD低40%(HR=0.60;95%CI 0.45-0.80;P<0.001)。
  • HHD组5年技术生存率为86.5%。
  • HHD提供更好的磷酸盐和血压控制,改善营养和炎症,减少住院天数和用药需求。

临床怎么用

  • 对于适合的患者,延长家庭血液透析可作为中心常规血液透析的替代选择,以改善生存和临床指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: More frequent and/or longer hemodialysis (HD) has been associated with improvements in numerous clinical outcomes in patients on dialysis. Home HD (HHD), which allows more frequent and/or longer dialysis with lower cost and flexibility in treatment planning, is not widely used worldwide. Although, retrospective studies have indicated better survival with HHD, this issue remains controversial. In this multicenter study, we compared thrice-weekly extended HHD with in-center conventional HD (ICHD) in a large patient population with a long-term follow-up. METHODS: We matched 349 patients starting HHD between 2010 and 2014 with 1047 concurrent patients on ICHD by using propensity scores. Patients were followed-up with from their respective baseline until September 30, 2018. The primary outcome was overall survival. Secondary outcomes were technique survival; hospitalization; and changes in clinical, laboratory, and medication parameters. RESULTS: The mean duration of dialysis session was 418 ± 54 minutes in HHD and 242 ± 10 minutes in patients on ICHD. All-cause mortality rate was 3.76 and 6.27 per 100 patient-years in the HHD and the ICHD groups, respectively. In the intention-to-treat analysis, HHD was associated with a 40% lower risk for all-cause mortality than ICHD (hazard ratio [HR] = 0.60; 95% confidence interval [CI] 0.45 to 0.80; P < 0.001). In HHD, the 5-year technical survival was 86.5%. HHD treatment provided better phosphate and blood pressure (BP) control, improvements in nutrition and inflammation, and reduction in hospitalization days and medication requirement. CONCLUSION: These results indicate that extended HHD is associated with higher survival and better outcomes compared to ICHD.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Ok E, Demirci C, Asci G, et al. Patient Survival With Extended Home Hemodialysis Compared to In-Center Conventional Hemodialysis. Kidney Int Rep. 2023. PMID: 38106580. doi:10.1016/j.ekir.2023.09.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。